Patents Assigned to Angiotech Pharmaceuticals, Inc.
-
Patent number: 9125814Abstract: Disclosed are hydrogel compositions formed by the mixture of a tetramethylmethane substituted with one or more polyethylene glycols, and wherein each polyethylene glycol substituent is independently further substituted with one or more electrophilic groups, and a tetramethylmethane substituted with one or more polyethylene glycols, and wherein each polyethylene glycol substituent is independently further substituted with one or more nucleophilic groups. Disclosed are also methods of preparing the above hydrogels. The hydrogel compositions can further comprise pharmaceuticals, such as analgesics or local anesthetics. Disclosed are also methods of sealing a wound, preventing post-surgical adhesion, and reducing post-surgical pain using the disclosed hydrogels.Type: GrantFiled: April 22, 2009Date of Patent: September 8, 2015Assignee: Angiotech Pharmaceuticals, Inc.Inventors: Yuehua He, Aniko Takacs-Cox, Anthony Boey, Brent Zaluski, Roger A. Smith, Audrey A. Deschamps, Rui Avelar
-
Publication number: 20130115263Abstract: Medical implants are provided which release a fluoropyrimidine or an analog thereof, thereby inhibiting or reducing the incidence of infection associated with the implant.Type: ApplicationFiled: October 29, 2012Publication date: May 9, 2013Applicant: Angiotech Pharmaceuticals, Inc.Inventor: Angiotech Pharmaceuticals, Inc.
-
Publication number: 20130102657Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.Type: ApplicationFiled: July 13, 2012Publication date: April 25, 2013Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: WILLIAM L. HUNTER, LINDSAY S. MACHAN, A. LARRY ARSENAULT
-
Patent number: 8221794Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.Type: GrantFiled: March 3, 2010Date of Patent: July 17, 2012Assignee: Angiotech Pharmaceuticals, Inc.Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault, Helen M. Burt, John J. Jackson, Stephen K. Dordunoo
-
Publication number: 20120101522Abstract: A method and device for anchoring a length of self-retaining suture. The method of anchoring includes providing for an assembly having a length of self-retaining suture and a suture insertion device. The length of suture includes at least a portion of the length having a plurality of retainers thereon extending in a first direction. The insertion device has a length and a recess to receive a portion of the suture length. The method further includes placing a portion of the suture length in the recess and inserting the device into the body of a mammal until the recess reaches a predetermined location thereby forming an insertion pathway. The method further includes retrieving the insertion device from the body by moving the insertion device in a direction substantially opposed to the insertion pathway.Type: ApplicationFiled: November 3, 2009Publication date: April 26, 2012Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: Anthony R. Megaro, Matthew A. Megaro
-
Patent number: 8118834Abstract: A self-retaining suture comprises a composite filament. The filament has retainers on the surface such that the filament can engage and retain tissue without knots. The filament comprises at least two materials having different properties. A surface material of the filament has properties which enhance the formation, elevation and/or deployment of the retainers. A core material of the filament has properties which enhance the tensile strength of the filament. The surgical filament is thin and flexible and may be used for suturing. Methods for manufacturing the filament and retainers are also described.Type: GrantFiled: December 19, 2008Date of Patent: February 21, 2012Assignee: Angiotech Pharmaceuticals, Inc.Inventors: Alexei Goraltchouk, Alexander Naimagon, Gerald F. Cummings, Lev Drubetsky, Robert A. Herrmann
-
Publication number: 20110319932Abstract: A marked heterofunctional suture thread has two or more sections having different features. One or more sections of the suture thread are provided with laser-marked and non-laser marked indicia in order that they may be identified and differentiated from other sections. The suture thread may have retainers on the surface of one or more sections such that the suture thread can engage and retain tissue without knots. The markers may be used to indicate fixed features of a section of suture thread such as the presence and/orientation of retainers. In particular embodiments, laser-marked and non-laser marked indicia are used to identify the transition section of a bidirectional self-retaining suture.Type: ApplicationFiled: December 16, 2010Publication date: December 29, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: Rui Avelar, Alexei Goraltchouk, Robert A. Herrmann, Brian H. Luscombe, William L. D'Agostino
-
Publication number: 20110264138Abstract: A marked heterofunctional surgical filament. The filament comprises two or more sections having different features, and the different sections of the filament are provided with markers in order that they may be identified and differentiated. The filament may have retainers on the surface of one or more sections such that the filament can engage and retain tissue without knots. The markers may be used to indicate fixed features of a section of filament such as the presence and/orientation of retainers. The markers may be utilized to indicate conditions of the filament such as tension. The markers may be directly readable or be machine-readable. The surgical filament is thin and flexible and may be used for suturing.Type: ApplicationFiled: May 16, 2009Publication date: October 27, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: Rui Avelar, Alexei Goraltchouk, Robert A. Herrmann, Brian H. Luscombe, William L. D'Agostino
-
Publication number: 20110264139Abstract: Sutures are used in combination with fibrosing agents to induce or stimulate fibrosis that between the sutures and the host tissues into which the sutures are inserted. Compositions and methods are described for use in lifting tissue, closing wound, and other applications.Type: ApplicationFiled: April 12, 2011Publication date: October 27, 2011Applicant: Angiotech Pharmaceuticals, Inc.Inventors: William L. HUNTER, Rui Avelar, David Gravett, Philip M. Toleikis, Arpita Maiti
-
Publication number: 20110166597Abstract: An embodiment of a suture for use in a surgical procedure applied to tissue comprises an elongated body having a first end and a second end, and a plurality of retainers arranged along a portion of the elongated body. The retainers substantially yield to motion of the elongated body within the tissue when the elongated body is drawn at the first end and resist motion of the elongated within the tissue when the elongated body is drawn at the second end. The retainers include an upper surface and a lower surface, the upper surface extending from a periphery of the elongated body and the lower surface having at least two facets.Type: ApplicationFiled: September 26, 2008Publication date: July 7, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: Robert A. Herrmann, Alexei Goraltchouk, Lev Drubetsky
-
Publication number: 20110118825Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.Type: ApplicationFiled: June 22, 2010Publication date: May 19, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
-
Publication number: 20110106152Abstract: An apparatus and method for cutting retainers on a continuous strand is provided. The apparatus may include a rotary head member configured to be rotatably driven about a longitudinal axis. The rotary head member may include a center hole substantially coincident with the longitudinal axis and configured to receive the strand. A retainer forming member may be supported on the rotary head member and may include a cutting edge directed substantially inward toward the longitudinal axis. When the rotary head member rotates about the longitudinal axis and the strand is continuously pulled through the center hole along the longitudinal axis, the cutting edge may intermittently or continuously cuts retainers about an outer surface of the strand.Type: ApplicationFiled: January 30, 2009Publication date: May 5, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventor: Martin J. Kozlowski
-
Publication number: 20110071612Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.Type: ApplicationFiled: June 17, 2010Publication date: March 24, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
-
Publication number: 20110066251Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.Type: ApplicationFiled: June 22, 2010Publication date: March 17, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: William L. HUNTER, Lindsay S. Machan, A. Larry Arsenault
-
Publication number: 20110056859Abstract: Suture packaging and methods of use related thereto, wherein sutures are stored in suture packaging (100) having a panel (102) with apertures (104), needle parks (106, 500) removably or fixedly and selectively inserted into the apertures, and wrapping pegs (108, 400) removably or fixedly and selectively inserted into the apertures. The suture package can further comprise a tab (716) and a tab slot (718) for closing the package.Type: ApplicationFiled: September 10, 2008Publication date: March 10, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventor: Martin J. Kozlowski
-
Publication number: 20110046668Abstract: Provided herein are sutures to be used in a procedure applied to tissue, and methods for forming such sutures. A suture can include an elongated suture body and a plurality of heat-contact mediated retainers extending from and along the elongated suture body. The heat-contact mediated retainers can be formed by temporarily contacting the elongated suture body with one or more heated element.Type: ApplicationFiled: December 19, 2008Publication date: February 24, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: Alexei Goraltchouk, Lev Drubetsky, Gerald F. Cummings, Robert A. Herrmann, Alexander Naimagon
-
Publication number: 20110046669Abstract: A method and device to elevate retainers on a suture thread to a desired angle such that the retainers can retain the desired elevation. The retainers can be elevated using an apparatus having at least one roller and at least one bending bar, wherein the bending bar contacts the retainers adjacent to the at least one roller to apply a force to the retainers. The retainers can also be elevated using a tube-shaped apparatus which allows the retainers on a suture thread to be bent by the inner surface of the tube-shaped apparatus. In various embodiments of the invention, a suture can be made up of an inner core and a coating that upon a stimuli increases the protrusion of the retainers away from the suture core thereby ensuring that the suture is held securely in place, preventing wound separation and dehiscence.Type: ApplicationFiled: February 20, 2009Publication date: February 24, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: Alexei Goraltchouk, Robert A. Herrmann, Lev Drubetsky, Jeffrey Mendel Gross, William L. D'Agostino, Carlos Gonzalez Resendiz
-
Publication number: 20110022086Abstract: The present invention combines synthetic, natural and recombinant polymers for making a self-retaining suture. In an embodiment of the present invention recombinant polyhydroxyalkanoate (rPHA) polymers and/or polyglycolic acid polymers are incorporated into the suture. In various embodiments of the invention, materials are incorporated into the suture to illicit a tissue response reaction. The tissue response reaction results in deposition of collagen around the tissue retainer in the tissue thereby increasing the retention of the tissue retainer in the tissue. In various embodiments of the invention, the core of the suture is made from a material that does not illicit a tissue response reaction. In various embodiments of the invention, the core can be chose to enhance elasticity and strength of the suture.Type: ApplicationFiled: October 31, 2008Publication date: January 27, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: William L. D'Agostino, Alexei Goraltchouk
-
Patent number: 7871425Abstract: Medical devices and methods are provided for a minimally-invasive mastoplasty procedure. In the procedure, barbed sutures are used to accomplish a nipple-lift by deploying the sutures cranially from the nipple-areolar complex to stable anatomical features higher on the chest. Additional barbed sutures may be used to accomplish a breast-lift and/or breast contouring by deploying the sutures caudally from stable anatomical features into the breast tissue.Type: GrantFiled: July 27, 2007Date of Patent: January 18, 2011Assignee: Angiotech Pharmaceuticals, Inc.Inventors: Richard G. Jones, Benjamin Schlechter
-
Publication number: 20110004121Abstract: A biopsy device handle for use with a biopsy device needle set, comprising a housing, a throw depth selection assembly, a cocking assembly, a carriage assembly, a needle set driver assembly, and an actuating assembly. A safety feature may be incorporated into the device to reduce or eliminate the chance of unintentional firing of the biopsy device.Type: ApplicationFiled: May 28, 2010Publication date: January 6, 2011Applicant: ANGIOTECH PHARMACEUTICALS INC.Inventors: Lev Drubetsky, Yakov (Jacob) Gofman